All Rankings

Top Biotech Startups in the UK 2026

Private biotechnology and genomics companies headquartered in the United Kingdom, ranked by disclosed lifetime funding.

Known total funding for 100 of 100 ranked companies: $12.9B.

Showing top 100 matching companies · Ranked by total funding raised

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&countries=United+Kingdom&operatingStatus=active&sort=total_funding_raised&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API can include out-of-scope company records; this core research list excludes them.

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant, private equity or debt financing; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant, Private Equity, Debt Financing are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

1
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series CTotal funding$2.6BNov 2026
2
OMass Therapeutics

Biotech company harnessing native mass spectrometry and chemistry to discover small molecule drug...

Oxford, United Kingdom11–50Biotech
Series CTotal funding$440.5MOct 2026
3
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$411.0MJan 2025
4
Beacon Therapeutics

Clinical-stage ophthalmic gene therapy company developing AAV-based treatments for rare and preva...

London, United Kingdom51–200Biotech
Series CTotal funding$365.0MJan 2026
5
CellCentric

CellCentric develops inobrodib, an oral small molecule inhibitor targeting p300 and CBP, to treat...

Cambridge, United Kingdom11–50Biotech, Healthcare
Series DTotal funding$340.0MMay 2026
6
Artios

Artios develops DNA damage response cancer medicines, advancing targeted therapies for solid tumo...

Cambridge, United Kingdom51–200Biotech
Series DTotal funding$301.2MNov 2025
7
F2G

F2G develops first-in-class medicines for patients and caregivers confronting rare, life-threaten...

Manchester, United Kingdom51–200Biotech, Healthcare
Venture RoundTotal funding$261.0MSep 2024
8
bit.bio

Cambridge-based biotech using opti-ox cell programming technology to produce precision human cell...

Cambridge, United Kingdom51–200Biotech, Healthcare
Series DTotal funding$249.5MNov 2026
9
Quell Therapeutics

Clinical stage company transforming lives in immune mediated disease

London, United Kingdom51–200Biotech, Healthcare
Series BTotal funding$240.0MNov 2021
10
T Therapeutics

T-Therapeutics develops first-in-class TCR-based medicines for cancer and autoimmune disease usin...

Cambridge, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$225.0MNov 2026
11
Basecamp Research

Builds evolutionary biological datasets and foundation AI models to design proteins and therapeut...

London, United Kingdom11–50Artificial Intelligence, Biotech
Series CTotal funding$220.0MSep 2026
12
BenevolentAI

AI-enabled drug discovery company using machine learning and knowledge graphs to identify novel d...

London, United Kingdom201–500Drug Discovery, Artificial Intelligence
Series DTotal funding$217.8MJan 2020
13
Crescendo Biologics

Humabody VH domain biologics for cancer and immunity

Cambridge, United Kingdom11–50Biotech, Healthcare
Extension RoundTotal funding$215.4MJul 2023
14
OLIX

Clinical-stage South Korean biopharmaceutical company developing RNA interference (RNAi) therapeu...

London, United Kingdom51–200Biotech
Series ATotal funding$213.0MFeb 2026
15
Cerevance

Cerevance develops cell-type specific treatments for neurodegenerative, psychiatric, and CNS-cont...

Cambridge, United Kingdom51–200Biotech
Series CTotal funding$209.5MMay 2026
16
Draig Therapeutics

Draig develops highly specific AMPA and GABAA receptor modulators to precisely address neuropsych...

Cardiff, United Kingdom1–10Biotech
Series BTotal funding$205.0MJul 2026
17
Pulmocide

UK biopharmaceutical company developing opelconazole, an inhaled antifungal therapy for pulmonary...

London, United Kingdom11–50Biotech, Healthcare
Extension RoundTotal funding$201.4MDec 2022
18
Pheon Therapeutics

Pheon Therapeutics develops antibody-drug conjugates based on novel targets and linker payloads t...

Harpenden, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$188.0MMay 2024
19
MiNA Therapeutics

RNA activation therapeutics company developing small activating RNA medicines to restore or boost...

London, United Kingdom11–50Biotech, Healthcare
Series CTotal funding$175.0MJan 2023
20
AviadoBio

AviadoBio is a biotechnology company developing transformative gene therapies for neurodegenerati...

London, United Kingdom51–200Biotech, Genomics
Series BTotal funding$168.5MApr 2025
21
Purespring

AAV-based gene therapies for kidney diseases

London, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$165.0MOct 2024
22
ENA Respiratory

Clinical-stage respiratory biotech developing novel treatments for respiratory diseases.

Melbourne, United Kingdom1–10Biotech, Healthcare
Series ATotal funding$162.4MJun 2026
23
Evox Therapeutics

Evox Therapeutics develops exosome-based genome editing medicines for genetically driven neurodeg...

Oxford, United Kingdom51–200Biotech, Healthcare
Series CTotal funding$153.8MFeb 2021
24
Cambridge Epigenetix

Cambridge Epigenetix is using epigenetics to reduce diagnostic tests for common cancers to a simp...

London, United Kingdom11–50Biotech, Healthcare
Series DTotal funding$144.5MNov 2021
25
Tropic Biosciences

We're making tropical agriculture more productive and sustainable by using cutting-edge genetic i...

Norwich, United Kingdom51–200Healthcare, Agtech
Series CTotal funding$143.5MMar 2026